Spinal Cord Injury Therapeutics Market Set to Witness Significant Growth by 2024-2031: AbbVie Inc, Pfizer Inc., NervGen
Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% by (2023-2030). BURLINGAME, CA, UNITED STATES, December 17, 2024 /EINPresswire.com/ -- Latest Report, titled “ …